At a glance
ClinicalIndex Comparison RecordN/ACompleted· 154 enrolled
Drug / intervention
GORE® TAG® Thoracic Endoprosthesesdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation on the Treatment of Diseases of the Thoracic Aorta With the Thoracic Endoprosthesis GORE® TAG®
In Brief
An observational study evaluating GORE® TAG® Thoracic Endoprostheses for Aortic Aneurysm, Thoracic and 4 related conditions. Completed, enrolled 154 participants across 1 site.
Detailed Summary
This is a French Registry mandated by the French National Health Authority assessing long-term (5-years) safety of the GORE® TAG® Thoracic Endoprosthesis treating diseases of the thoracic aorta.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAortic Aneurysm, Thoracic, Descending Thoracic Aortic Dissection, Aortic Diseases, Aorta Thoracic; Traumatic Rupture, Penetrating Ulcer
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartOct 2014
First PostedOct 2014
Primary CompletionDec 2021
Study CompletionApr 2022
TodayJul 2026
First PostedOct 17, 2014
Enrollment StartOct 1, 2014
Primary CompletionDec 1, 2021
Study CompletionApr 1, 2022
TodayJul 2, 2026
Enrollment to primary: 7.2 yearsPosted 11.7 years ago
Interventions
GORE® TAG® Thoracic Endoprosthesesdevice
Endovascular therapy to treat thoracic disease